DNTH
Dianthus Therapeutics Inc (DNTH) Investor Questions
Review Dianthus Therapeutics Inc (DNTH) faq with server-rendered company data, supporting context and links to related investor research.
- Company
- Dianthus Therapeutics Inc
- Sector
- Healthcare
- Industry
- Biotechnology
- Overall BTI score
- 50
- Annual revenue
- $2.04M
- Annual net income
- $-162.34M
- Annual free cash flow
- $-129.27M
Dianthus Therapeutics Inc (DNTH) Investor Questions research
Dianthus Therapeutics Inc trades under the ticker DNTH. The company is classified in the Healthcare sector and the Biotechnology industry.
Investors commonly review DNTH through its earnings trend, revenue, free cash flow, balance sheet, valuation and historical risk. The linked research sections provide a separate crawlable page for each data-rich topic.